NeuroSense Therapeutics Ltd. ( NRSN) - Stock Earnings
NRSN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -1.8 million USD | — USD |
| 2025Q1 | -2.4 million USD | — USD |
| 2025Q2 | -2.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NRSN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.1 million USD | — USD |
| 2024 | -10.2 million USD | — USD |
| 2025 | -11.1 million USD | — USD |
| 2026 Est. | — | — |
NRSN
Price: $2.39
52 week price:
Earnings Per Share: -0.44 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 108700
Market Capitalization: 7.0 million